The up to $1.4M collaboration will enable manufacturing “universal” islets containing a drug-inducible safety feature designed to make curative therapies accessible without the need for chronic ...

According to the ’40 Under 40′ list of business elites in China released by Fortune (Chinese Edition), Simon Yeung, the ...